COVID-19 Genomics Initiative at the Wellcome Sanger Institute
Parasites and Microbes
We provide high throughput genomic monitoring of the SARS-CoV-2 virus in the UK, aiding public health officials in their response to the coronavirus pandemic. We also monitor the virus for genetic mutations which could cause it to be more easily transmitted or to escape vaccines.
As part of COG-UK, the Sanger Institute is sequencing the genomes of tens of thousands of coronavirus samples, from people in communities across the country. Our group combines statistical and computational expertise to analyse those genomes, and detect new variants of the virus. We are working closely with public health authorities to integrate this data with their work. Tracking variants will help public health officials guide their responses.
We are also monitoring the virus genome sequence for any mutations which could affect how vaccines work.
Dr Jeffrey Barrett
Director of the COVID-19 Genomics Initiative at the Wellcome Sanger Institute
Jeff has rejoined the Wellcome Sanger Institute to help build the Sanger Institute’s comprehensive Covid-19 genomic surveillance programme in the UK. Previously Jeff was Director of Open Targets, an open innovation partnership to use cutting-edge genomic results to improve the early stages of drug development. His research team at Sanger analyzed thousands of genomes to better understand the biology of a wide range of complex disorders.
Previous team members
The Wellcome Sanger Institute's technological platforms underpin our ability to carry out biomedical research on a large scale, allowing researchers ...
High-Throughput DNA Sequencing
The High Throughput DNA sequencing team within DNA Pipelines Operations is a highly automated high throughput team specialising in producing libraries ...